- Notes on the Contributors
- Methods in Bioethics
- The Way We Reason Now: Reflective Equilibrium in Bioethics
- Mental Disorder, Moral Agency, and the Self
- ‘Reinventing’ the Rule of Double Effect
- Policy‐Making in Pluralistic Societies
- Tiers Without Tears: the Ethics of a Two‐Tier Health Care System
- Justice and the Elderly
- Organ Transplantation
- For Dignity or Money: Feminists on the Commodification of Women's Reproductive Labour
- The Definition of Death
- The Aging Society and the Expansion of Senility: Biotechnological and Treatment Goals
- Death is a Punch in the Jaw: Life‐Extension and its Discontents
- Precedent Autonomy, Advance Directives, and End‐of‐Life Care
- Physician‐Assisted Death: the State of the Debate
- Abortion Revisited
- Moral Status, Moral Value, and Human Embryos: Implications for Stem Cell Research
- Therapeutic Cloning: Politics and Policy
- Population Genetic Research and Screening: Conceptual and Ethical Issues
- Genetic Interventions and The Ethics of Enhancement of Human Beings
- Pharmacogenomics: Ethical and Regulatory Issues
- Clinical Equipoise: Foundational Requirement or Fundamental Error?
- Research on Cognitively Impaired Adults
- Research in Developing Countries
- Animal Experimentation
- The Implications of Public Health for Bioethics
- Global Health
- Bioethics and Bioterrorism
Abstract and Keywords
This article looks at some of the chance discoveries and elegant ideas that were borne out through the availability of archived tissue samples. It then discusses some of the planned changes to the method and purpose of tissue storage and collection. The changes are in the form of new types of tissue bank, or biobank as they are conceived. These banks are part of a trend to move towards a preventative approach to public health rather than the current costly interventionist model. This approach is not without its problems and it is these that threaten the unfettered continuation of the tissue archive. The sophistication of new research tools can uncover information about individuals that may have a detrimental effect on their well-being in various ways. The article analyses these possibilities in the context of how health care might develop.
Louise Irving was formerly at the Institute of Medicine, Law, and Bioethics at the University of Manchester, where she was a research fellow on a three‐year project, funded by the European Commission, which seeks to develop a legal and ethical framework for stem‐cell research. She has written on the commodification of the human body, the relationship between analytic moral philosophy and bioethics, and issues of public health. Her main research interest is in the nature of freedom.
John Harris is Sir David Alliance Professor of Bioethics at the Institute of Medicine, Law, and Bioethics, University of Manchester. In 2001 he was the first philosopher to have been elected a Fellow of the Academy of Medical Sciences. He has been a member of the Human Genetics Commission since its foundation in 1999. The author or editor of fourteen books and over 150 papers, his recent books include Bioethics (Oxford University Press, 2001), A Companion to Genetics: Philosophy and the Genetic Revolution, co‐edited with Justine Burley (Blackwell, 2002), and On Cloning (Routledge, 2004).